Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Kohinoor Industries

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000197 7 linked products · source seen 10 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx7product presentations
G5generic molecules
DF2dosage-form groups
TA3therapeutic areas
PKR7current price records
REG7registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage71%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixKohinoor IndustriesShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/kohinoor-industriesGenerated 10 Aug 2026Pain & musculoskeletal4 · 57%Anti-infectives2 · 29%Gastrointestinal & hepatology1 · 14%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioKohinoor IndustriesDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/kohinoor-industriesGenerated 10 Aug 20267presentationsSuspension4 · 57%Capsule3 · 43%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionKohinoor IndustriesCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/kohinoor-industriesGenerated 10 Aug 20265comparable productsBelow market median0 · 0%Near market median4 · 80%Above market median1 · 20%Company median price position0.0%Lowest-price equivalents0Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsKohinoor IndustriesCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/kohinoor-industriesGenerated 10 Aug 2026M/s. Genix Pharma (Pvt) Ltd.5 shared100% overlapAtco Laboratories Limited5 shared100% overlapMediate Pharmaceutical Pvt Ltd5 shared100% overlapZafa Pharmaceutical Laboratories (P…5 shared100% overlapValor Pharmaceuticals5 shared100% overlapGlobal Pharmaceuticals Pvt Ltd5 shared100% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Pain & musculoskeletal4 products · 57%
Anti-infectives2 products · 29%
Gastrointestinal & hepatology1 products · 14%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Analgesics / NSAIDs4 products · 57%
Macrolide antibacterials1 products · 14%
Tetracycline antibacterials1 products · 14%
Proton pump inhibitors1 products · 14%
Formulation footprint

Dosage forms

Suspension4 products
Capsule3 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 Aztika AztikaAzithromycin 1presentations 250 mg · Capsule #2 K-dox K-DoxDoxycycline 1presentations 100 mg · Capsule #3 Kcifin Kcifin /5m1Ibuprofen 1presentations 100 mg/5 mL · Suspension #4 Kcifin Kcifin DSIbuprofen 1presentations 200 mg/5 mL · Suspension #5 KomizoleOmeprazole 1presentations 20 mg · Capsule #6 Neopol NeopolParacetamol 1presentations 120 mg/5 mL · Suspension
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median00% of comparable products
Near market median4within ±5% of median
Above market median120% of comparable products
Lowest-price equivalents0ties included
Company median price position 0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
K-dox K-Dox 100 mgDoxycycline · Capsule · 100's PKR 7.68/capsule-1.2% vs market median Neopol Neopol 120 mg/5 mLParacetamol · Suspension · 60ml PKR 1.05/mL-0.1% vs market median Aztika Aztika 250 mgAzithromycin · Capsule · 6's PKR 48.47/capsule0.0% vs market median Komizole 20 mgOmeprazole · Capsule · 14's PKR 20.24/capsule+3.5% vs market median Kcifin Kcifin /5m1 100 mg/5 mLIbuprofen · Suspension · 120ml PKR 1.08/mL+13.8% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 5shared generics Atco Laboratories Limited275 products · 94 generics 5shared generics Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 5shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.239 products · 98 generics 5shared generics Valor Pharmaceuticals218 products · 97 generics 5shared generics Global Pharmaceuticals Pvt Ltd211 products · 80 generics 5shared generics
Regulatory & price activity

Observed database signals

Registration numbers7
Price-history records7
Products with price history0
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date1 Jul 2025
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

7 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Aztika Aztika Azithromycin 250 mg Capsule 6's 124521 PKR 290.81 PKR 48.47/capsule Near median
K-dox K-Dox Doxycycline 100 mg Capsule 100's 124522 PKR 767.53 PKR 7.68/capsule Near median
Kcifin Kcifin /5m1 Ibuprofen 100 mg/5 mL Suspension 120ml 124519 PKR 129.12 PKR 1.08/mL 14% above median
Kcifin Kcifin DS Ibuprofen 200 mg/5 mL Dry suspension 90ml 124520 PKR 118.08 PKR 1.31/mL No comparator
Komizole Omeprazole 20 mg Capsule 14's 124516 PKR 283.39 PKR 20.24/capsule Near median
Neopol Neopol Paracetamol 120 mg/5 mL Suspension 60ml 124517 PKR 62.87 PKR 1.05/mL Near median
Neopol Neopol DS Paracetamol 250 mg/5 mL Dry suspension 60ml 124518 PKR 90.49 PKR 1.51/mL No comparator
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.